Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Biological Assay × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoproliferative Disorders 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 48 Carboplatin 41 Pemetrexed 35 Specimen Handling 34 Magnetic Resonance Spectroscopy 34 Cisplatin 26 Blood Specimen Collection 24 Paclitaxel 16 durvalumab 14 Radiosurgery 14 Radiotherapy 13 osimertinib 12 Nivolumab 12 Gemcitabine 12 Biopsy 12 Bevacizumab 12 atezolizumab 11 Practice Guidelines as Topic 10 Educational Status 9 Docetaxel 9 130-nm albumin-bound paclitaxel 9 X-Rays 8 Standard of Care 8 Immunoglobulin G 8 Taxes 7 Surveys and Questionnaires 7 Etoposide 7 Drug Therapy 7 Disulfides 7 Cetuximab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06716580 2025-12-10

EQUAL

Dana-Farber Cancer Institute

Phase NA Recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡